Endopeptidase-ELISA

LB Laura von Berg
DS Daniel Stern
DP Diana Pauly
SM Stefan Mahrhold
JW Jasmin Weisemann
LJ Lisa Jentsch
EH Eva-Maria Hansbauer
CM Christian Müller
MA Marc A. Avondet
AR Andreas Rummel
MD Martin B. Dorner
BD Brigitte G. Dorner
request Request a Protocol
ask Ask a question
Favorite

The endopeptidase-ELISA was performed according to Jones et al.55 using a slightly modified protocol. 3 µg/mL of rSNAP-25H6 or H6trVAMP-2 diluted in 50 mM carbonate-buffer (pH 9.6) were coated on MaxiSorp microtitre plates overnight at 4 °C. On the next day, coating solution was decanted and plates were blocked with 5% skimmed milk powder PBS-T for 90 minutes at room temperature. Subsequently, plates were washed with ddH2O (4 × ), dried, and toxin diluted in cleavage buffer (see above) was added. Plates were incubated for 18 h at 37 °C with constant back and forth movement in a hybridisation oven (Biometra GmbH, Göttingen, Germany) for substrate cleavage. Plates were then washed with PBS-T (4×) and incubated with 100 µL neoepitope-specific antibodies diluted to 1 µg/mL in 2% skimmed milk powder PBS-T for 90 minutes at room temperature on a multiwell plate shaker (IKA, Staufen, Germany) at 300 rpm for the detection of cleavage products. After incubation with Neo-mAbs, plates were washed again with PBS-T (4×) and incubated with 100 µL HRP-coupled goat anti-mouse IgG H + L (1:2500 dilution, Dianova, Hamburg, Germany) secondary antibody diluted in 2% skimmed milk powder PBS-T for 30 minutes at room temperature on a multiwell plate shaker at 300 rpm. Finally, plates were washed with PBS-T (8×) and developed as described above.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A